Ploidy Analysis and Ki-67 Expression in Myelodysplastic Syndromes

Area of Science:

• Hematology
• Oncology
• Cell Biology

Background:

• Myelodysplastic syndromes (MDS) involve abnormal bone marrow cell growth, potentially leading to marrow failure or acute leukemia.
• Understanding factors influencing MDS progression is crucial for patient management.

Purpose of the Study:

• To investigate the correlations between clinical factors, MDS subtypes, DNA ploidy, and Ki-67 expression.
• To identify markers that differentiate between high- and low-grade MDS.

Main Methods:

• Analysis of Feulgen-stained bone marrow smears from 27 MDS patients for DNA ploidy using image analysis.
• Examination of Ki-67 expression (MIB-1 antibody) in bone marrow biopsy specimens from 25 patients.
• Recording of clinical data including age, sex, bone marrow cellularity, and MDS grade.

Main Results:

• 16 diploid and 11 aneuploid cases were identified.
• Ki-67 expression (MIB-1+) ranged from 6.4% to 61.7% (mean 37.7%).
• High-grade MDS correlated with younger age, male sex, lower S-phase percentage, higher cellularity, and greater MIB-1 expression.
• Low-grade MDS correlated with older age, female sex, lower cellularity, and lower MIB-1 expression, with a higher S-phase percentage.

Conclusions:

• Ki-67 expression and S-phase percentage, alongside clinical parameters and MDS subtype, can differentiate distinct MDS patient groups.
• These factors may partially explain the differing biologic behavior observed between high- and low-grade MDS.